DK175052B1 - Forbedret fremgangsmåde til fremstilling af Amphotericin B liposomer - Google Patents

Forbedret fremgangsmåde til fremstilling af Amphotericin B liposomer Download PDF

Info

Publication number
DK175052B1
DK175052B1 DK198806293A DK629388A DK175052B1 DK 175052 B1 DK175052 B1 DK 175052B1 DK 198806293 A DK198806293 A DK 198806293A DK 629388 A DK629388 A DK 629388A DK 175052 B1 DK175052 B1 DK 175052B1
Authority
DK
Denmark
Prior art keywords
amphotericin
liposomes
complex
amphiphilic
phospholipid
Prior art date
Application number
DK198806293A
Other languages
Danish (da)
English (en)
Other versions
DK629388D0 (da
DK629388A (da
Inventor
Richard Thomas Proffitt
Jill Adler-Moore
Su-Ming Chiang
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Publication of DK629388D0 publication Critical patent/DK629388D0/da
Publication of DK629388A publication Critical patent/DK629388A/da
Application granted granted Critical
Publication of DK175052B1 publication Critical patent/DK175052B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
DK198806293A 1987-11-12 1988-11-11 Forbedret fremgangsmåde til fremstilling af Amphotericin B liposomer DK175052B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11951887A 1987-11-12 1987-11-12
US11951887 1987-11-12

Publications (3)

Publication Number Publication Date
DK629388D0 DK629388D0 (da) 1988-11-11
DK629388A DK629388A (da) 1989-05-13
DK175052B1 true DK175052B1 (da) 2004-05-10

Family

ID=22384831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198806293A DK175052B1 (da) 1987-11-12 1988-11-11 Forbedret fremgangsmåde til fremstilling af Amphotericin B liposomer

Country Status (14)

Country Link
US (2) US6770290B1 (ja)
EP (1) EP0317120B1 (ja)
JP (1) JP2958774B2 (ja)
KR (1) KR970007187B1 (ja)
AT (1) ATE66598T1 (ja)
AU (1) AU598958B2 (ja)
CA (1) CA1339008C (ja)
DE (1) DE3864495D1 (ja)
DK (1) DK175052B1 (ja)
ES (1) ES2029330T3 (ja)
GR (1) GR3003050T3 (ja)
HK (1) HK119893A (ja)
IE (1) IE62110B1 (ja)
NO (1) NO178484C (ja)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2653245B2 (ja) * 1989-11-27 1997-09-17 日本新薬株式会社 脂肪乳剤
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US20040175417A1 (en) * 1990-10-19 2004-09-09 Gilead Sciences, Inc. Amphotericin B liposome preparation
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
EP0556392A4 (en) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd PROCESS FOR PRODUCING A FATTY EMULSION.
AU1201192A (en) * 1991-01-14 1992-08-17 Board Of Regents, The University Of Texas System Anti-hiv activity of liposomal nystatin and amphotericin b
EP0584063A1 (en) * 1991-05-16 1994-03-02 Vestar, Inc. Methods for the administration of drugs
US5720973A (en) * 1993-02-18 1998-02-24 Knoll Aktiengesellschaft Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor
DE4305003A1 (de) * 1993-02-18 1994-08-25 Knoll Ag Verfahren zur Herstellung kolloidaler wäßriger Lösungen schwer löslicher Wirkstoffe
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
GB9609779D0 (en) 1996-05-10 1996-07-17 Univ Bruxelles Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof
AU758351B2 (en) * 1998-08-25 2003-03-20 Alkermes, Inc. Stable spray-dried protein formulations
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
CA2394833A1 (en) 2000-01-14 2001-07-19 Binh T. Dang Derivatives of polyene macrolides and preparation and use thereof
US6428975B1 (en) 2000-01-14 2002-08-06 Blue Ridge Pharmaceuticals, Inc. Methods for determining the presence or absence of microorganisms in lipid-containing compositions
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
KR100743404B1 (ko) * 2000-12-21 2007-07-30 넥타르 테라퓨틱스 폴리엔 항균제의 폐 전달
JP4555569B2 (ja) * 2001-11-13 2010-10-06 セレーター ファーマシューティカルズ， インコーポレイテッド 増強された血中安定性を有する脂質キャリア組成物
WO2004030677A1 (en) * 2002-10-03 2004-04-15 University Of Mississippi Compositions comprising highly purified amphotericin b
US8648050B2 (en) * 2002-10-03 2014-02-11 University Of Mississippi Methods and formulations for reducing amphotericin B treatment side effects
US8980310B2 (en) * 2002-12-31 2015-03-17 Bharat Serums and Vaccines, Ltd. Non-pegylated long-circulating liposomes
WO2004064731A2 (en) * 2003-01-14 2004-08-05 University Of Washington Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues
DE10339358A1 (de) * 2003-08-27 2005-03-24 Cognis Deutschland Gmbh & Co. Kg Verwendung von Liposomen zur Ausrüstung von Fasern und Textilien
CN1893926B (zh) * 2003-11-20 2010-09-08 Ym生物科学有限公司 包含含有药物成分的亲脂胺的稳定脂质体组合物
US20050169978A1 (en) * 2004-01-29 2005-08-04 Shu-Wen Fu Wet-micro grinding
ITRM20040223A1 (it) * 2004-05-07 2004-08-07 Sigma Tau Ind Farmaceuti Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
JP4758915B2 (ja) * 2004-08-06 2011-08-31 バイオスペクトラム，インコーポレイテッド 多重層リポソームおよびその製造方法
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
EP1929073A4 (en) * 2005-09-27 2010-03-10 Amunix Inc PROTEIN MEDICAMENT AND ITS USE
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
CA2841386A1 (en) 2005-12-30 2007-07-12 Zensun (Shanghai) Science & Technology Limited Extended release of neuregulin for improved cardiac function
US20070154546A1 (en) * 2005-12-30 2007-07-05 Zhang Jack Y Sustained release pharmaceutical compositions
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
KR20100017928A (ko) * 2007-05-25 2010-02-16 더 유니버시티 오브 브리티쉬 콜롬비아 치료제의 경구 투여를 위한 제제 및 관련 방법
CA2695374A1 (en) * 2007-08-15 2009-02-19 Amunix, Inc. Compositions and methods for modifying properties of biologically active polypeptides
CN102348715B (zh) 2009-02-03 2017-12-08 阿穆尼克斯运营公司 延伸重组多肽和包含该延伸重组多肽的组合物
US8716448B2 (en) 2009-02-03 2014-05-06 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
PT2440228T (pt) 2009-06-08 2018-12-24 Amunix Operating Inc Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos
EP2440241B1 (en) 2009-06-08 2017-08-09 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US8956600B2 (en) * 2009-08-10 2015-02-17 Taiwan Liposome Co. Ltd. Ophthalmic drug delivery system containing phospholipid and cholesterol
WO2011050457A1 (en) * 2009-10-26 2011-05-05 The University Of British Columbia Stabilized formulation for oral administration of therapeutic agents and related methods
BR112012009801A8 (pt) 2009-10-30 2016-08-30 Cns Therapeutics Inc Polipeptídeo neurturina e variante de neurturina
MX365184B (es) 2010-12-21 2019-05-21 Centro De Investig Y De Estudios Avanzados Del I P N Nuevos compuestos analogos de la anfotericina y composiciones farmaceuticas que los contienen.
CN111548418A (zh) 2012-02-15 2020-08-18 比奥贝拉蒂治疗公司 因子viii组合物及其制备和使用方法
KR20190094480A (ko) 2012-02-15 2019-08-13 바이오버라티브 테라퓨틱스 인크. 재조합 인자 viii 단백질
TW202003554A (zh) 2013-08-14 2020-01-16 美商百歐維拉提夫治療公司 因子ｖｉｉｉ－ｘｔｅｎ融合物及其用途
KR101484080B1 (ko) * 2013-08-26 2015-01-19 동국제약 주식회사 봉입률과 저장안정성이 개선된 암포테리신 b를 함유한 리포좀 제제의 제조방법, 및 이로부터 제조된 리포좀 제제
KR102242875B1 (ko) 2014-03-25 2021-04-20 더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 리프리젠티드 바이 더 세크리터리 오브 더 아미 모노포스포릴 지질 a (mpla)-함유 리포솜 조성물 및 사포닌을 포함하는 무독성 아주반트 제제
JP2015193580A (ja) * 2014-03-31 2015-11-05 テルモ株式会社 アムホテリシンｂリポソームの製造方法
DE102015102210A1 (de) 2015-02-16 2016-08-18 Heraeus Medical Gmbh Antimykotischer polymerisierbarer Knochenzement und ein Verfahren zu seiner Herstellung
JP6909203B2 (ja) 2015-08-03 2021-07-28 バイオベラティブ セラピューティクス インコーポレイテッド 第ｉｘ因子融合タンパク質及びそれらの製造方法及び使用方法
EP3150196A1 (en) * 2015-09-30 2017-04-05 Sun Pharma Advanced Research Company Ltd Process for the preparation of unilamellar liposomal composition
IL286493B (en) 2015-11-06 2022-07-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogs, methods for their production, preparations containing them and their uses
WO2019075214A2 (en) * 2017-10-11 2019-04-18 The Board Of Trustees Of The University Of Illinois INDEPENDENT RESCUEING OF THE GENOTYPE OF CYSTIC FIBROSIS WITH BICARBONATE CHANNELS WITH SMALL MOLECULES
CA3075822A1 (en) 2017-10-16 2019-04-25 Adjuvance Technologies, Inc. Triterpene saponin analogues
US20210369615A1 (en) * 2018-07-31 2021-12-02 Ico Therapeutics Inc. Solid oral formulations of amphotericin b
US11273124B2 (en) 2019-05-23 2022-03-15 Brown University Antifungal nanoparticles for targeted treatment of fungal infections
WO2023175454A1 (en) 2022-03-14 2023-09-21 Pfizer Inc. Methods for producing an adjuvant
WO2023205615A1 (en) * 2022-04-18 2023-10-26 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions & methods of their use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394149A (en) 1978-02-24 1983-07-19 Szoka Jr Francis C Plant nutriment compositions and method of their application
US4310505A (en) 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4419348A (en) * 1981-04-27 1983-12-06 Georgetown University Anthracycline glycoside compositions, their use and preparation
US4497791A (en) 1983-02-10 1985-02-05 Vestar Research Incorporated Method for labeling phagocytic cells
GB2135647A (en) 1983-02-15 1984-09-05 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4663167A (en) * 1984-04-16 1987-05-05 The Board Of Regents Of The University Of Texas System Composition and method for treatment of disseminated fungal infections in mammals
US4978654A (en) * 1984-04-16 1990-12-18 Board Of Regents, The University Of Texas System Composition and method for treatment of disseminated fungal infections in mammals
PT78628B (en) 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4880635B1 (en) 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1298548C (en) 1984-10-22 1992-04-07 Cary Arnet Presant Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
US4766046A (en) 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method
DK175531B1 (da) * 1986-12-15 2004-11-22 Nexstar Pharmaceuticals Inc Leveringsvehikel med amphiphil-associeret aktiv bestanddel
NZ223660A (en) 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders

Also Published As

Publication number Publication date
IE883394L (en) 1989-05-12
AU2416188A (en) 1989-05-18
JP2958774B2 (ja) 1999-10-06
ES2029330T3 (es) 1992-08-01
JPH01160915A (ja) 1989-06-23
HK119893A (en) 1993-11-12
US6770290B1 (en) 2004-08-03
ATE66598T1 (de) 1991-09-15
DK629388D0 (da) 1988-11-11
US5965156A (en) 1999-10-12
DE3864495D1 (de) 1991-10-02
IE62110B1 (en) 1994-12-14
DK629388A (da) 1989-05-13
KR970007187B1 (ko) 1997-05-07
NO884989D0 (no) 1988-11-09
GR3003050T3 (en) 1993-02-17
NO178484B (no) 1996-01-02
AU598958B2 (en) 1990-07-05
EP0317120A1 (en) 1989-05-24
KR890007718A (ko) 1989-07-05
CA1339008C (en) 1997-03-25
NO178484C (no) 1996-04-10
EP0317120B1 (en) 1991-08-28
NO884989L (no) 1989-05-16

Similar Documents

Publication Publication Date Title
DK175052B1 (da) Forbedret fremgangsmåde til fremstilling af Amphotericin B liposomer
EP1143933B1 (en) Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
Zarif et al. Cochleates: new lipid-based drug delivery system
US4950432A (en) Polyene microlide pre-liposomal powders
EP0153364A1 (en) IMPROVING THE ANTIMICROBIAL EFFECT BY CONNECTING A MIXTURE OF ANTIMICROBIAL AGENTS IN LIPID VIALS.
JP3245955B2 (ja) リポソーム
US20110020428A1 (en) Gel-stabilized liposome compositions, methods for their preparation and uses thereof
DE602004011982T2 (de) Verfahren zur Beladung von therapeutischen Mitteln in vorgeformte Liposomen und das dabei erhaltene Produkt
AU3111401A (en) New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
CN100348198C (zh) 单唾液酸四已糖神经节苷脂脂质体复合物制剂
US20040175417A1 (en) Amphotericin B liposome preparation
CN101011407B (zh) 两性霉素b脂质体抗真菌滴眼液及其制备方法
Myint AmBisome: an overview of current use
JPH0655676B2 (ja) 脂質小胞体中に含有された抗菌物質の混合物による抗菌活性の増高
JPS59500952A (ja) 安定なプルリラメラベシクル類
BR112020026629A2 (pt) Composições farmacêuticas na forma liofilizada
HU191858B (en) Process for production of stabil plurilamerrical vesicula
AU2004200967A1 (en) Novel hydrogel isolated ochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
PL197939B1 (pl) Liposomowy preparat zawierający przeciwnowotworową substancję aktywną, sposób jego wytwarzania i zawierająca go kompozycja farmaceutyczna
AU2007200813A1 (en) Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules

Legal Events

Date Code Title Description
PUP Patent expired